Clinical Trial Simulation Market Size, Share, Growth, and Forecast 2032 : BAMG Consulting
Clinical Trial Simulation Market to Reach USD 2.79 Billion by 2032, Driven by AI, Model-Informed Drug Development & Rising Clinical Trial Costs – New Report by BMAG Consulting New Delhi, India – September 10, 2026: BMAG Consulting, a leading market intelligence and business research firm, has released its latest report on the Clinical Trial Simulation Market , highlighting the growing adoption of computational modeling, artificial intelligence, quantitative pharmacology, model-informed drug development, and simulation-based clinical trial design across the global pharmaceutical and biotechnology industries. According to BMAG Consulting, the Clinical Trial Simulation Market was valued at USD 1.54 billion in 2025 and is projected to reach USD 2.79 billion by 2032, expanding at a CAGR of 8.87% during 2025–2032 . North America is expected to maintain its market leadership, while Asia-Pacific is projected to record the fastest growth during the forecast period. Clinical trial simulatio...